Publicaciones en las que colabora con Manuel Díez Alonso (17)

2022

  1. The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study

    Colorectal Disease, Vol. 24, Núm. 6, pp. 708-726

2021

  1. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  2. Impact of COVID-19 on vascular patients worldwide: Analysis of the COVIDSurg data

    Journal of Cardiovascular Surgery, Vol. 62, Núm. 6, pp. 558-570

  3. Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

    Colorectal Disease, Vol. 23, Núm. 3, pp. 732-749

2003

  1. Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer

    International Journal of Cancer, Vol. 107, Núm. 5, pp. 781-790

1997

  1. Prognostic value of flow cytometric DNA analysis in non-small-cell lung cancer: Rationale of sequential processing of frozen and paraffin-embedded tissue

    World Journal of Surgery, Vol. 21, Núm. 3, pp. 323-329

1996

  1. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma

    Cancer, Vol. 77, Núm. 6, pp. 1066-1072

  2. Escherichia coli resistance to amoxicillin and co-amoxiclav in a community with high aminopenicillin consumption rate

    Revista Espanola de Quimioterapia

1995

  1. Concordance between serum and cytosolic levels of CEA CA125 and SCC antigens in patients with non-small cell lung cancer

    Anticancer Research, Vol. 15, Núm. 6 B, pp. 2811-2817

  2. Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer

    International Journal of Biological Markers, Vol. 10, Núm. 1, pp. 5-10

1994

  1. Epidermal growth factor receptor in non-small cell cancer of the lung

    Archivos de bronconeumología, Vol. 30, Núm. 6, pp. 282-286

  2. Prognostic significance of serum ca 125 antigen assay in patients with non‐small cell lung cancer

    Cancer, Vol. 73, Núm. 5, pp. 1368-1376

  3. Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non‐small cell lung cancer

    Cancer, Vol. 73, Núm. 9, pp. 2305-2311

1993

  1. UTILIDAD DEL ANTIGENO CA 125 EN SUERO COMO FACTOR PRONOSTICO DE SUPERVIVENCIA EN PACIENTES CON CARCINOMA PULMONAR NO MICROCITICO

    Neoplasia, Vol. 10, Núm. 6, pp. 192-196

  2. Value of serum neuron-specific enolase in nonsmall cell lung cancer

    Oncology, Vol. 50, Núm. 2, pp. 127-131

1991

  1. Evaluation of serum ca 125 as a tumor marker in non‐small cell lung cancer

    Cancer, Vol. 67, Núm. 1, pp. 150-154

1986

  1. Complicaciones en la cirugía del cáncer del esófago y cardias.

    Revista Espanola de las Enfermedades del Aparato Digestivo, Vol. 70, Núm. 5, pp. 407-410